Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient
Details for Australian Patent Application No. 2007311946 (hide)
International Classifications
Event Publications
28 May 2009 PCT application entered the National Phase
PCT publication WO2008/047914 Priority application(s): WO2008/047914
4 June 2009 Amendment Made
The nature of the amendment is: Amend the invention title to read Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007311957-Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
2007311917-The manufacturing method of construction materials using waterworks sludge
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser